Olema Pharmaceuticals, Inc.(OLMA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OLMA Olema Pharmaceuticals, Inc.

交易中 01-13 09:41:41 EST

28.16

-0.63

-2.21%

最高28.51	最低27.86	成交量4.53万
今开28.22	昨收28.79	日振幅2.27%
总市值22.15亿	流通市值14.96亿	总股本7,866万
成交额127.70万	换手率0.09%	流通股本5,314万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OLMA","market":"US","secType":"STK","nameCN":"Olema Pharmaceuticals, Inc.","latestPrice":28.155,"timestamp":1768315291695,"preClose":28.79,"halted":0,"volume":45307,"delay":0,"floatShares":53144399,"shares":78659900,"eps":-1.806432,"marketStatus":"交易中","change":-0.635,"latestTime":"01-13 09:41:41 EST","open":28.22,"high":28.5132,"low":27.86,"amount":1276996.597405,"amplitude":0.022688,"askPrice":28.28,"askSize":107,"bidPrice":28.01,"bidSize":105,"shortable":3,"etf":0,"ttmEps":-1.806432,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"listingDate":1605762000000,"exchange":"NASDAQ","adjPreClose":28.79,"preHourTrading":{"tag":"盘前","latestPrice":28.34,"preClose":28.79,"latestTime":"09:23 EST","volume":315,"amount":8968.027005,"timestamp":1768314222293},"postHourTrading":{"tag":"盘后","latestPrice":28.78,"preClose":28.79,"latestTime":"19:43 EST","volume":14438,"amount":415907.0716,"timestamp":1768265001734},"volumeRatio":0.838385,"impliedVol":0.7535,"impliedVolPercentile":0.2669},"requestUrl":"/m/hq/s/OLMA","defaultTab":"news","newsList":[{"id":"2592125021","title":"Olema Pharmaceuticals, Inc.盘中异动 急速跳水5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592125021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592125021?lang=zh_cn&edition=full","pubTime":"2025-12-20 01:24","pubTimestamp":1766165050,"startTime":"0","endTime":"0","summary":"北京时间2025年12月20日01时24分，Olema Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.36%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.34%。其相关个股中，Novabay Pharmaceuticals, Inc.、爱美医疗、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Psyence Biomedical Ltd.、In8Bio, Inc.、Neuraxis, Inc.较为活跃，换手率分别为1708.23%、219.92%、134.03%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Geovax Labs, Inc.、Novabay Pharmaceuticals, Inc.，振幅分别为59.53%、57.35%、43.56%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。OP-3136是该公司产品管线中的另一款候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220012410a6b803ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220012410a6b803ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","OLMA","BK4139"],"gpt_icon":0},{"id":"1161965582","title":"Olema Pharmaceuticals：销售协议招募书涵盖高达2亿美元普通股的发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1161965582","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161965582?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:52","pubTimestamp":1765489959,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals：销售协议招募书涵盖高达2亿美元普通股的发行","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","OLMA","BK4139"],"gpt_icon":0},{"id":"2590580110","title":"生物制药公司OLEMA PHARMA美股盘前涨超32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590580110","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590580110?lang=zh_cn&edition=full","pubTime":"2025-12-10 21:23","pubTimestamp":1765372980,"startTime":"0","endTime":"0","summary":"每经AI快讯，12月10日，生物制药公司OLEMA PHARMA美股盘前涨超32%。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-10/doc-inhaiqhx0327392.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-10/doc-inhaiqhx0327392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2087625088.SGD","LU0097036916.USD","LU0056508442.USD","BK4551","LU2360107168.USD","IE00BZ9MQY76.HKD","LU1861215975.USD","BK4608","IE00B19Z9P08.USD","LU0353189763.USD","LU2360106780.USD","BK4588","LU0353189680.USD","BK4587","BK4023","LU1861220033.SGD","BK4613","OLMA","IE00B19Z9Z06.USD","BK4528","LU2290526834.HKD","IE00B894F039.SGD","LU2063271972.USD","BK4543","LU1852331112.SGD","BK4585","BK4539","LU2250418816.HKD"],"gpt_icon":0},{"id":"1150775324","title":"Olema Oncology公布1.9亿美元普通股公开发售定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1150775324","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150775324?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:23","pubTimestamp":1763630629,"startTime":"0","endTime":"0","summary":"11月19日 - Olema Pharmaceuticals Inc ：*Olema Oncology公布1.9亿美元普通股公开发售定价*Olema Oncology公布1.9亿美元普通股公开发售定价*Olema Pharmaceuticals Inc - 此次公开发售定价为1000万股，每股定价19.00美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OLMA","BK4505"],"gpt_icon":0},{"id":"1119558883","title":"异动解读 | Olema Pharmaceuticals夜盘大涨5.35%，此前宣布1.9亿美元股票发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1119558883","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119558883?lang=zh_cn&edition=full","pubTime":"2025-11-20 11:56","pubTimestamp":1763610985,"startTime":"0","endTime":"0","summary":"生物制药公司Olema Pharmaceuticals周三夜盘交易中股价大涨5.35%，引发投资者关注。这一涨幅出现在该公司此前宣布发行1.9亿美元股票之后，显示市场对公司融资计划反应积极。根据消息，Olema Pharmaceuticals在股价近期大涨后宣布发行1.9亿美元股票。生物制药行业通常需要大量资金投入，此次融资有助于Olema增强财务实力。值得注意的是，尽管公司宣布大规模股票发行通常会导致股价下跌，但Olema股价却出现上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OLMA"],"gpt_icon":0},{"id":"1111138815","title":"异动解读 | Olema制药盘中大涨5.26%，竞品临床成功推动行业上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1111138815","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111138815?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:52","pubTimestamp":1763563944,"startTime":"0","endTime":"0","summary":"Olema制药周三盘中大涨5.26%，延续了本周的强劲涨势。这波涨势主要受到竞争对手罗氏公司的口服乳腺癌药物在晚期临床试验中取得积极结果的提振。周二，Olema股价飙升136%，创下四年来新高。尽管周三早盘公司宣布以19美元的价格发行1000万股新股，筹资1.9亿美元，但投资者情绪仍然高涨。分析师对Olema保持乐观态度。这表明市场认为该公司在乳腺癌治疗领域具有巨大潜力，尽管面临融资稀释，但长期前景依然看好。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OLMA"],"gpt_icon":0},{"id":"1107782238","title":"异动解读 | Olema制药盘前大跌6.80%，终止ATM招股说明书并宣布新股发行计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1107782238","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107782238?lang=zh_cn&edition=full","pubTime":"2025-11-19 17:04","pubTimestamp":1763543078,"startTime":"0","endTime":"0","summary":"生物制药公司Olema Pharmaceuticals周三盘前股价大跌6.80%，延续了夜盘交易中的下跌趋势。这一显著跌幅主要源于公司最新公布的一系列财务决策。分析人士指出，终止ATM招募说明书可能意味着Olema Pharmaceuticals正在调整其融资策略。而新股和认股权证的发行计划则可能导致现有股东权益被稀释，这无疑加剧了市场的抛售压力。市场将密切关注公司管理层对这些举措的进一步解释，以及它们对Olema Pharmaceuticals长期发展的潜在影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OLMA"],"gpt_icon":0},{"id":"1160962997","title":"异动解读 | Olema Pharmaceuticals夜盘大跌8.59%，终止ATM招股说明书并宣布新股发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1160962997","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160962997?lang=zh_cn&edition=full","pubTime":"2025-11-19 09:02","pubTimestamp":1763514147,"startTime":"0","endTime":"0","summary":"生物制药公司Olema Pharmaceuticals在夜盘交易中遭遇重创，股价暴跌8.59%。这一显著跌幅主要源于公司最新公布的一系列财务决策。根据公司向美国证券交易委员会提交的文件，Olema Pharmaceuticals已决定终止其于2025年1月6日生效的普通股At-The-Market招募说明书。分析人士指出，终止ATM招募说明书可能意味着Olema Pharmaceuticals正在调整其融资策略。市场将密切关注公司管理层对这些举措的进一步解释，以及它们对Olema Pharmaceuticals长期发展的潜在影响。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OLMA"],"gpt_icon":0},{"id":"1109913417","title":"Olema Oncology股价下跌3.9%，至19.36美元，因宣布拟发行股票和预先融资的认股权证","url":"https://stock-news.laohu8.com/highlight/detail?id=1109913417","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109913417?lang=zh_cn&edition=full","pubTime":"2025-11-19 06:25","pubTimestamp":1763504709,"startTime":"0","endTime":"0","summary":"Olema Oncology股价下跌3.9%，至19.36美元，因宣布拟发行股票和预先融资的认股权证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA","BK4139","BK4505"],"gpt_icon":0},{"id":"1140736220","title":"异动解读 | Olema Pharmaceuticals盘后大跌5.66%，终止普通股ATM招募说明书","url":"https://stock-news.laohu8.com/highlight/detail?id=1140736220","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140736220?lang=zh_cn&edition=full","pubTime":"2025-11-19 05:52","pubTimestamp":1763502764,"startTime":"0","endTime":"0","summary":"生物制药公司Olema Pharmaceuticals在盘后交易中大幅下跌5.66%，引起投资者关注。根据公司向美国证券交易委员会提交的文件显示，Olema Pharmaceuticals已决定终止其于2025年1月6日生效的普通股At-The-Market招募说明书。这一举动可能是导致股价下跌的主要原因。ATM发行是上市公司筹集资金的一种灵活方式，允许公司根据市场情况逐步出售新股。终止ATM招募说明书可能意味着Olema Pharmaceuticals改变了其融资策略，或者当前不再需要通过这种方式筹集额外资金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OLMA"],"gpt_icon":0},{"id":"1114896510","title":"Olema Pharmaceuticals Inc - 终止2025年1月6日的普通股ATM招募说明书 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1114896510","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114896510?lang=zh_cn&edition=full","pubTime":"2025-11-19 05:30","pubTimestamp":1763501409,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals Inc - 终止2025年1月6日的普通股ATM招募说明书 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA","BK4139","BK4505"],"gpt_icon":0},{"id":"2584997315","title":"Alector, Inc.盘中异动 股价大涨5.65%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584997315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584997315?lang=zh_cn&edition=full","pubTime":"2025-11-19 01:59","pubTimestamp":1763488799,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日01时59分，Alector, Inc.股票出现异动，股价急速拉升5.65%。截至发稿，该股报1.31美元/股，成交量68.0555万股，换手率0.62%，振幅7.26%。Alector, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Olema Pharmaceuticals, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Arvinas, Inc.涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为1965.98%、1139.97%、436.10%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为106.34%、60.49%、59.39%。Alector, Inc.公司简介：Alector Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119015959a4aad60c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119015959a4aad60c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALEC","OLMA"],"gpt_icon":0},{"id":"1197477714","title":"Olema Oncology在2025年欧洲肿瘤内科年会上发布Palazestrant联合Ribociclib在ER+/HER2-转移性乳腺癌的1B/2期临床试验新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1197477714","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197477714?lang=zh_cn&edition=full","pubTime":"2025-10-18 15:05","pubTimestamp":1760771109,"startTime":"0","endTime":"0","summary":"Olema Oncology在2025年欧洲肿瘤内科年会上发布Palazestrant联合Ribociclib在ER+/HER2-转移性乳腺癌的1B/2期临床试验新数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA","BK4139","BK4505"],"gpt_icon":0},{"id":"2569748455","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大涨5.02%报8.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569748455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569748455?lang=zh_cn&edition=full","pubTime":"2025-09-23 23:37","pubTimestamp":1758641875,"startTime":"0","endTime":"0","summary":"北京时间2025年09月23日23时37分，Olema Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.02%。截至发稿，该股报8.75美元/股，成交量20.3956万股，换手率0.30%，振幅3.84%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Adverum Biotechnologies, Inc.、Galecto, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Galecto, Inc.、Silo Pharma, Inc.、Soligenix, Inc.较为活跃，换手率分别为3610.21%、335.06%、164.40%，振幅较大的相关个股有Adverum Biotechnologies, Inc.、Galecto, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为47.68%、40.33%、38.24%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092323375695406b8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092323375695406b8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","OLMA","BK4139"],"gpt_icon":0},{"id":"2566895630","title":"Olema Pharmaceuticals, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566895630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566895630?lang=zh_cn&edition=full","pubTime":"2025-09-08 21:45","pubTimestamp":1757339147,"startTime":"0","endTime":"0","summary":"北京时间2025年09月08日21时45分，Olema Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.11%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Rapport Therapeutics, Inc.、Genprex, Inc.、Equillium, Inc.涨幅较大，Cdt Equity Inc.、Genprex, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为736.69%、231.57%、64.75%，振幅较大的相关个股有Genprex, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Ethzilla Corporation C/Wts 06/11/2025，振幅分别为45.01%、44.37%、39.35%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。OP-3136是该公司产品管线中的另一款候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908214548978143dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908214548978143dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLMA","BK4505","BK4139"],"gpt_icon":0},{"id":"1135125183","title":"Olema Oncology宣布与辉瑞达成新临床试验协议，将Palazestrant与Atirmociclib联合用于ER+/HER2-转移性乳腺癌治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1135125183","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135125183?lang=zh_cn&edition=full","pubTime":"2025-09-02 19:01","pubTimestamp":1756810881,"startTime":"0","endTime":"0","summary":"Olema Oncology宣布与辉瑞达成新临床试验协议，将Palazestrant与Atirmociclib联合用于ER+/HER2-转移性乳腺癌治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0234572021.USD","LU1057294990.SGD","IE0002270589.USD","LU0289739699.SGD","BK4007","LU0306807586.USD","BK4533","PFE","BK4534","IE000M9KFDE8.USD","LU1883839398.USD","IE00BLSP4239.USD","LU0456855351.SGD","LU0321505868.SGD","LU1894683348.USD","BK4585","IE00B19Z3581.USD","LU1066053197.SGD","SG9999013999.USD","BK4588","OLMA","LU0170899867.USD","SG9999001176.SGD","BK4592","LU0306806265.USD","LU1894683264.USD","SGXZ57979304.SGD","BK4505","SG9999002224.SGD","IE00BLSP4452.SGD","BK4581","BK4599","LU0058720904.USD","BK4139","LU1023059063.AUD","BK4550","LU1066051498.USD","LU0985481810.HKD","SG9999011175.SGD","SG9999003800.SGD","SG9999001176.USD","IE00BBT3K403.USD","BK4568","LU0868494617.USD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","LU0225284248.USD","SG9999002232.USD"],"gpt_icon":0},{"id":"2559268496","title":"Olema Pharmaceuticals, Inc.盘中异动 早盘股价大涨11.49%报5.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559268496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559268496?lang=zh_cn&edition=full","pubTime":"2025-08-12 21:31","pubTimestamp":1755005507,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日21时31分，Olema Pharmaceuticals, Inc.股票出现波动，股价大幅上涨11.49%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Tnf Pharmaceuticals, Inc.、X4制药、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为739.33%、457.47%、76.58%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Tuhura Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为29.82%、17.87%、15.23%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812213155a6e1d1c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812213155a6e1d1c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLMA","BK4139","BK4505"],"gpt_icon":0},{"id":"2557308764","title":"Olema Pharmaceuticals, Inc.盘中异动 大幅下挫5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557308764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557308764?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:05","pubTimestamp":1754489140,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时05分，Olema Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.40%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Bioxcel Therapeutics, Inc.、Biomx Inc.、诺瓦瓦克斯医药涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为482.61%、329.85%、33.48%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.、Bioxcel Therapeutics, Inc.，振幅分别为45.15%、30.79%、28.96%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。OP-3136是该公司产品管线中的另一款候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622054194d38946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622054194d38946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","OLMA"],"gpt_icon":0},{"id":"2556437018","title":"Olema Pharmaceuticals, Inc.盘中异动 下午盘大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556437018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556437018?lang=zh_cn&edition=full","pubTime":"2025-08-02 03:24","pubTimestamp":1754076240,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日03时24分，Olema Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.06%。截至发稿，该股报5.40美元/股，成交量39.9355万股，换手率0.58%，振幅8.03%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Equillium, Inc.、4D Molecular Therapeutics, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Bioxcel Therapeutics, Inc.、Equillium, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为1771.31%、329.27%、302.17%，振幅较大的相关个股有Equillium, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、天境生物，振幅分别为253.15%、72.18%、59.20%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802032401a6ce460f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802032401a6ce460f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","OLMA"],"gpt_icon":0},{"id":"2555702315","title":"Olema Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555702315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555702315?lang=zh_cn&edition=full","pubTime":"2025-07-30 23:55","pubTimestamp":1753890950,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日23时55分，Olema Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.09%。Olema Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Replimune Group, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Tnf Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Replimune Group, Inc.较为活跃，换手率分别为362.91%、201.97%、173.87%，振幅较大的相关个股有Replimune Group, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为54.00%、53.86%、47.44%。Olema Pharmaceuticals, Inc.公司简介：Olema Pharmaceuticals inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073023555097281ac3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073023555097281ac3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","OLMA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.olema.com","stockEarnings":[{"period":"1week","weight":0.147},{"period":"1month","weight":-0.1289},{"period":"3month","weight":1.6806},{"period":"6month","weight":5.3136},{"period":"1year","weight":4.7123},{"period":"ytd","weight":0.1516}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Olema Pharmaceuticals, Inc.位于加利福尼亚州的旧金山，于2006年8月7日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于发现，开发和商业化针对女性癌症的下一代靶向疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.111727},{"month":2,"riseRate":0,"avgChangeRate":-0.163352},{"month":3,"riseRate":0,"avgChangeRate":-0.127785},{"month":4,"riseRate":0.4,"avgChangeRate":0.019027},{"month":5,"riseRate":0.6,"avgChangeRate":0.034553},{"month":6,"riseRate":0.8,"avgChangeRate":0.218999},{"month":7,"riseRate":0.6,"avgChangeRate":0.146122},{"month":8,"riseRate":0.6,"avgChangeRate":0.005399},{"month":9,"riseRate":0.6,"avgChangeRate":0.128302},{"month":10,"riseRate":0.4,"avgChangeRate":0.060003},{"month":11,"riseRate":0.4,"avgChangeRate":0.234387},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.111549}],"exchange":"NASDAQ","name":"Olema Pharmaceuticals, Inc.","nameEN":"Olema Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Olema Pharmaceuticals, Inc.(OLMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Olema Pharmaceuticals, Inc.(OLMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Olema Pharmaceuticals, Inc.,OLMA,Olema Pharmaceuticals, Inc.股票,Olema Pharmaceuticals, Inc.股票老虎,Olema Pharmaceuticals, Inc.股票老虎国际,Olema Pharmaceuticals, Inc.行情,Olema Pharmaceuticals, Inc.股票行情,Olema Pharmaceuticals, Inc.股价,Olema Pharmaceuticals, Inc.股市,Olema Pharmaceuticals, Inc.股票价格,Olema Pharmaceuticals, Inc.股票交易,Olema Pharmaceuticals, Inc.股票购买,Olema Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Olema Pharmaceuticals, Inc.(OLMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Olema Pharmaceuticals, Inc.(OLMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}